// App-Quantinova.ai

M4265 2015 AHA : Impact of Diabetes Mellitus on the Prognosis of Patients with Heart Failure and Preserved Left Ventricle Ejection Fraction: Insights From the TOPCAT Study

Researchers

Presenter

  • Brian Harty

Principal Investigators

  • Susan Assmann

  • Eileen -Meara

  • Inder Anand

  • Jerome Fleg

  • Natl Heart

  • Brian Claggett

  • Bertram Pitt

  • Jean Rouleau

Medical Centers

  • Brigham & Women's Hospital, Boston, MA

  • New England Research Institutes, Watertown, MA

  • University of Michigan, Ann Arbor, MI

  • McGill Univ Health Ctr, Montreal, Canada

  • New England Research Institutes, Watertown, MA

  • Univ of Minnesota Medical Sch, Montreal, MN

  • Blood and Lung Inst, Betheseda, MD

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Myocardial infarction

  • Intracerebral hemorrhage

  • Diabetes

  • Cardiac arrest

  • Congestive heart failure

  • Stroke

  • Type 2 diabetes mellitus

  • Heart failure with preserved ejection fraction

  • Type 1 diabetes mellitus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved